Compound Detail
CHEMBL4475215
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COC(=O)CCNC(=O)c1cc2cc(NC(=O)c3cc(NC(=O)CCCOc4cc5c(cc4OC)C(=O)N4c6ccccc6C[C@H]4C=N5)cn3C)ccc2s1
Basic Information
| ChEMBL ID | CHEMBL4475215 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VBJGVIKNCMQFOA-MHZLTWQESA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
762.9
MW (Da)
5.88
ALogP
11
HBA
3
HBD
169.7
PSA (Ų)
0.10
QED
3
Ro5 Violations
13
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 10.52
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NAMALVA | IC50 | = | 0.03 | nM | 10.52 | Cytotoxicity against human NAMALWA cells assessed as reduction in cell viability... | 31350125 |
| KB | IC50 | = | 0.04 | nM | 10.4 | Cytotoxicity against human KB cells assessed as reduction in cell viability afte... | 31350125 |
| Unchecked | IC50 | = | 0.2 | nM | 9.7 | Cytotoxicity against human NCI-H2110 cells assessed as reduction in cell viabili... | 31350125 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31350125 | 10.1016/j.bmcl.2019.07.031 | KB | 1 |
| 31350125 | 10.1016/j.bmcl.2019.07.031 | Unchecked | 1 |
| 31350125 | 10.1016/j.bmcl.2019.07.031 | NAMALVA | 1 |
Data from ChEMBL 36 via Core Engine